In a phase 2a atopic dermatitis study, maintenance of response continued for months after last dose; this may hint at an option for extended medication intervals.
Advice, words of encouragement and ideas for self-care from an experienced emergency physician to the younger generation.
The results of a preliminary study suggest the efficacy of heterologous anti-COVID vaccination not only for the completion of vaccination but also for a possible "third dose".
Researchers found molecular alterations in alcoholism causing impaired executive control and alcohol craving. Preclinical research showed psychedelics restored molecular deficits and reduced relapse behaviour.
A study by the University of Buenos Aires suggests the importance of investigating the effects of psychedelic drugs in the contexts in which they are naturally consumed, in order to obtain less artificial results.
Dispatching the public via an app as lay responders has shown to be accompanied by a 28% higher survival in patients with out-of-hospital cardiac arrest.
Paediatric patients with RRI and/or chronic cough (CC) have a higher incidence of impaired response to PCV13 compared with the general population.
The results of a study in healthy volunteers presented by Dr. Anna Becker suggest that SSRIs should not be discontinued prior to psilocybin treatment.
In a British general hospital, not a single patient tested positive for influenza nor respiratory syncytial virus (RSV) during the peak flu season in January 2021.
As COVID measures relaxed, pollution increased. Oxidative stress and systematic inflammation in healthy individuals was observed.
The digital HERB system proved successful in early-stage hypertension patients, which could lower their blood pressure and adopt positive lifestyle interventions.
The STEP trial revealed that lowering systolic blood pressure below 130 mmHg in +60 year-old patients led to a 26% reduction of adverse cardiovascular events.
Dr. Anna Ciaunica gave an insight into her work at the INSIGHT 2021 Conference and explained how the COVID-19 crisis-induced lack of tactile experience favours a depersonalitation disorder.
Psychedelic therapy and psychotherapy - differences and similarities and potential problems for therapists. Prof. Matthew Johnson (Johns Hopkins University) shared his work at the INSIGHT 2021 Conference.
Psychedelics could represent a new treatment approach in psychiatry. But can they combat the global health crisis? At the INSIGHT 2021 Conference, Prof. Dr. Gerhard Gründer takes a critical look on the issue.
For neuroscientist Dr. Martha Havenith, psychedelics are not the only way to explore altered states of consciousness. She works with voluntary hyperventilation (Breathwork) to achieve different perceptions.
Assigning all survivors of an out-of-hospital cardiac arrest (OHCA) to an early coronary angiogram turned out to have no positive influence on the 30-day all-cause mortality.
Thromboprophylaxis with a heparin therapeutic dose greatly reduced major thromboembolic events in COVID-19 hospitalisations compared with standard therapy.
In parts of public discourse and scientific literature, psychedelic therapies are claimed to transform and revolutionise psychiatry and mental healthcare. Can psychedelics live up to this claim?
The MICHELLE trial found rivaroxaban thrombo-prophylaxis beneficial for COVID-19 patients. Some individuals had a 67% risk reduction in clinical outcome composites.